Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.24(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1657
-0.0026(-0.22%)
GBP/USD
1.2548
+0.0015(+0.12%)
Bitcoin GBP
50,860.56
-56.84(-0.11%)

Meet one of the UK’s largest unknown start-ups

Video editing platform Veed has grown to 10 million users

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

4.7600

+0.2300

(+5.08%)

At close: 04:00PM EDT

4.7500

-0.01

(-0.21%)

After hours:

04:30PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	543.79M
Enterprise value	494.67M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	40.13
Price/book (mrq)	4.89
Enterprise value/revenue	49.50
Enterprise value/EBITDA	-7.71

Trading information

Stock price history

Beta (5Y monthly)	1.81
52-week change ³	164.91%
S&P500 52-week change ³	22.38%
52-week high ³	9.3900
52-week low ³	1.1800
50-day moving average ³	5.7669
200-day moving average ³	3.2041

Share statistics

Avg vol (3-month) ³	1.82M
Avg vol (10-day) ³	803.47k
Shares outstanding ⁵	114.24M
Implied shares outstanding ⁶	114.24M
Float ⁸	87.82M
% held by insiders ¹	6.66%
% held by institutions ¹	64.43%
Shares short (15 Apr 2024) ⁴	4.74M
Short ratio (15 Apr 2024) ⁴	4.93
Short % of float (15 Apr 2024) ⁴	4.64%
Short % of shares outstanding (15 Apr 2024) ⁴	4.15%
Shares short (prior month 15 Mar 2024) ⁴	3.79M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	3,149.63%

Management effectiveness

Return on assets (ttm)	-86.56%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	9.99M
Revenue per share (ttm)	0.12
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-64.53M
Net income avi to common (ttm)	-119.76M
Diluted EPS (ttm)	-1.4200
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	49.9M
Total cash per share (mrq)	0.47
Total debt (mrq)	777k
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.76
Book value per share (mrq)	-0.20

Cash flow statement

Operating cash flow (ttm)	-55.17M
Levered free cash flow (ttm)	7.74M